SCHEMBL1940677

SCHEMBL1940677

COCCNC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL11416469 0.97 HPGD (0.47)
Hydrochloric Acid SCHEMBL11161525 0.97
SCHEMBL7611838 0.95 HPGD (0.46)
SCHEMBL909869 0.89 DDAH1 (0.43)
SCHEMBL16333302 0.86 SMN1; SMN2 (0.48)
SCHEMBL15663598 0.86 ALDH1A1 (0.42)
SCHEMBL2836201 0.86 SMN1; SMN2 (0.48)
SCHEMBL21456865 0.86 SMN1; SMN2 (0.48)
SCHEMBL17293736 0.86 SMN1; SMN2 (0.48)
SCHEMBL2719858 0.86 SMN1; SMN2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024024-A9 SYSTEMS AND METHODS FOR SEPARATION OF CARBON DIOXIDE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-03-27 WO claimed
WO-2025024024-A1 SYSTEMS AND METHODS FOR SEPARATION OF CARBON DIOXIDE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-01-30 WO claimed
US-20250034721-A1 SYSTEMS AND METHODS FOR SEPARATION OF CARBON DIOXIDE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-01-30 US claimed
US-11130750-B2 Calcium channel inhibitors CAVION, INC. (US) 2021-09-28 US claimed
US-20200385367-A1 CALCIUM CHANNEL INHIBITORS CAVION, INC. 2020-12-10 US claimed
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 EP claimed
EP-3609888-A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF Metacrine, Inc. (US) 2020-02-19 EP claimed
EP-3555096-A1 IMIDAZOPYRROLOPYRIDINE AS INHIBITORS OF THE JAK FAMILY OF KINASES Janssen Pharmaceutica NV (BE) 2019-10-23 EP claimed
EP-3284792-B1 METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME INKTEC CO LTD (KR) 2019-10-09 EP claimed
EP-2066497-B1 MANUFACTURING METHODS FOR METAL CLAD LAMINATES INKTEC CO LTD (KR) 2018-11-07 EP claimed
CN-1898234-A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORP (US) 2007-01-17 CN claimed
EP-1680424-A2 HETEROARYL FUSED PYRIDINES, PYRAZINES AND PYRIMIDINES AS CRF1 RECEPTOR LIGANDS Neurogen Corporation (US) 2006-07-19 EP claimed
US-20050113344-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION 2005-05-26 US claimed
US-20050113379-A1 Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands AVENTIS PHARMACEUTICALS, INC. 2005-05-26 US claimed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 US claimed
WO-2005023806-A2 HETEROARYL FUSED PYRIDINES, PYRAZINES AND PYRIMIDINES AS CRF1 RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2005-03-17 WO claimed
US-20040142999-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2004-07-22 US claimed
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
US-4866119-A BACKINGS FOR WOVEN PILE FABRICS NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1989-09-12 US claimed